Illumina, Inc. - Common Stock (NQ:ILMN)

288.79 +9.32 (+3.33%)

Delayed Quote Updated: 4:00 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

40 41 Next >

Nvidia's AI Reign Ignites Stock Futures: A Trillion-Dollar Trajectory Reshapes the Market

September 30, 2025

San Francisco, CA – September 30, 2025 – Nvidia Corporation (NASDAQ: NVDA) continues its unprecedented ascent, cementing its position as the undisputed titan of the artificial intelligence (AI) era. As...

Via MarketMinute

Illumina Inc (NASDAQ:ILMN) Presents a Compelling Value Investment Case ↗

September 30, 2025

Illumina (ILMN) presents a strong value case with attractive valuation metrics, high profitability, and solid financial health, making it a compelling stock for value investors.

Via Chartmill

3 Healthcare Stocks That Fall Short

September 26, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

What Does the Market Think About Illumina? ↗

August 04, 2025

Via Benzinga

AI Takes Center Stage in Biodefense: DARPA's NODES Program Promises to Revolutionize Pandemic and Biowarfare Protection

September 25, 2025

In a groundbreaking leap for global health security, the Defense Advanced Research Projects Agency (DARPA) officially launched its Network of Optimal Dynamic Energy Signatures (NODES) program in July...

Via MarketMinute

Topics Artificial Intelligence

Trump Administration Review Targets Medical Supply Chain Vulnerabilities ↗

September 25, 2025

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—including PPE, consumables, and medical devices—to assess reliance on foreign...

Via Benzinga

Topics Economy Government Supply Chain

The Healthcare Horizon: Navigating Innovation, Policy Shifts, and Evolving Patient Care

September 19, 2025

The global healthcare industry is currently in the midst of a profound metamorphosis, characterized by a rapid influx of technological innovation, significant shifts in policy, and evolving patient...

Via MarketMinute

Topics Artificial Intelligence

My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years ↗

September 18, 2025

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds of billions dollars in revenue.

Via Benzinga

Why Illumina (ILMN) Stock Is Falling Today

September 12, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.2% in the afternoon session after reports emerged of increased competition from a Chinese rival and news of a significant legal settlement.

Via StockStory

Topics Economy Lawsuit Whistleblower

Astrana Health, Privia Health, Illumina, Waters Corporation, and LeMaitre Shares Plummet, What You Need To Know

September 10, 2025

A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.

Via StockStory

Topics Economy

Illumina (ILMN): Buy, Sell, or Hold Post Q2 Earnings?

September 08, 2025

Illumina has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 14.6% to $98.50 per share while the index has gained 15.5%.

Via StockStory

Topics Government Stocks

ILLUMINA INC (NASDAQ:ILMN) Screens as a Decent Value Stock for Investors ↗

September 06, 2025

Discover Illumina Inc (ILMN), a potential value investing opportunity with strong valuation, profitability, and solid growth forecasts.

Via Chartmill

Life Sciences Tools & Services Stocks Q2 Results: Benchmarking Illumina (NASDAQ:ILMN)

August 31, 2025

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the life sciences tools & services industry, including Illumina (NASDAQ:ILMN) and its...

Via StockStory

Topics Artificial Intelligence Economy

AdaptHealth, Illumina, Globalstar, Iridium, and Alight Shares Are Soaring, What You Need To Know

August 22, 2025

A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested...

Via StockStory

Topics ETFs Economy

3 Cash-Producing Stocks We Keep Off Our Radar

August 22, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Icahn Hedge Fund's Q2 Moves: Centuri Stake Soars, JetBlue Held, 2 Positions Exited ↗

August 15, 2025

Carl Icahn's 13F shows concentrated equity book, with top 10 holdings making up 98.76%. Notable changes in non-house names like CTRI and IFF.

Via Benzinga

NICE Stock Stops Being Nice, Has A Bearish Breakdown ↗

August 15, 2025

NICE Ltd. has ended a 15-year trend with a bearish breakdown, signaling extended downside risk. Here's what the Adhishthana Principles reveal...

Via Benzinga

Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know

August 13, 2025

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer...

Via StockStory

Topics Economy

Illumina’s Q2 Earnings Call: Our Top 5 Analyst Questions

August 13, 2025

Illumina’s second quarter performance in 2025 was met with a significant negative market reaction, as shares declined in response to ongoing revenue contraction and sharply lower operating margins....

Via StockStory

Topics Earnings World Trade

ILMN Q2 Deep Dive: Clinical Demand Cushions Revenue Decline Amid Research Weakness and Margin Pressures

August 13, 2025

Genomics company Illumina (NASDAQ:ILMN) reported Q2 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 3% year on year to $1.06 billion. Its non-GAAP profit of $1.19 per share...

Via StockStory

Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know

August 12, 2025

A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve.

Via StockStory

Topics Bonds Economy Stocks

Latin America’s Next-Generation Sequencing (NGS) Market Set to Reach $597.2 Million by 2034, Driven by Cancer Genomics and Personalized Medicine

August 07, 2025

Via AB Newswire

Illumina Settles With DOJ, Veterans To End Whistleblower Lawsuit ↗

August 06, 2025

Illumina will pay $9.8 million to settle allegations it sold genomic systems with cybersecurity flaws to U.S. agencies. A whistleblower will receive $1.9 million.

Via Benzinga

Topics Whistleblower

PacBio (PACB) Q2 Earnings Report Preview: What To Look For

August 05, 2025

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results this Thursday afternoon. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence World Trade

Earnings To Watch: 10x Genomics (TXG) Reports Q2 Results Tomorrow

August 05, 2025

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting results this Thursday after market hours. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence Economy World Trade

Illumina (ILMN) Q2 2025 Earnings Call Transcript ↗

August 03, 2025

Via The Motley Fool

Topics Earnings

Cathie Wood's Ark Invest Loads Up On Coinbase, Roku, Illumina, And Bitmine Immersion ↗

August 02, 2025

Cathie Wood-led Ark Invest made significant trades in COIN, ROKU, ILMN, and BMNR. They also bought PD and SOFI, sold KTOS and RBLX.

Via Benzinga

Illumina (ILMN) Q2 EPS Jumps 9% ↗

August 01, 2025

Via The Motley Fool

Why Illumina (ILMN) Shares Are Falling Today

August 01, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) fell 6.1% in the afternoon session as investors reacted to its second-quarter earnings report, where a year-over-year revenue decline overshadowed...

Via StockStory

Topics Artificial Intelligence World Trade

These Analysts Boost Their Forecasts On Illumina Following Upbeat Results ↗

August 01, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

40 41 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.